| Source: |
| Type: |
| CCAAT/enhancer‐binding protein beta (CEBPB) CEBPB is a transcription factor that regulates genes involved in proliferation, differentiation, immune responses, and inflammation. – In some contexts, high expression of CEBPB correlates with aggressive tumor behavior and poor clinical outcomes, whereas in other settings it might indicate a more differentiated state and, consequently, a less aggressive phenotype. - CEBPB expression was obviously elevated in CRC patients, and was associated with poor survival. |
| 2877- | HNK, | Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer |
| - | in-vitro, | GC, | AGS |
| 2178- | itraC, | Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer |
| - | in-vivo, | CRC, | HCT116 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1259 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid